Evaluation of neurovascular coupling during neuroprotective therapies: A single site HEAL ancillary study.

We demonstrate no difference in neurovascular coupling after Epo administration. These findings are consistent with overall negative trial results. Physiological biomarkers can help elucidate mechanisms of neuroprotective therapies in real time in future trials.